Eaton Vance Management’s Kyntra Bio, Inc. Common Stock KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.23M | Hold |
|
|||||
|
2022
Q2 | $998K | Hold |
|
|||||
|
2022
Q1 | $1.14M | Hold |
|
|||||
|
2021
Q4 | $1.33M | Hold |
|
|||||
|
2021
Q3 | $966K | Hold |
|
|||||
|
2021
Q2 | $2.52M | Hold |
|
|||||
|
2021
Q1 | $3.28M | Hold |
|
|||||
|
2020
Q4 | $3.5M | Hold |
|
|||||
|
2020
Q3 | $3.88M | Hold |
|
|||||
|
2020
Q2 | $3.83M | Sell |
|
|||||
|
2020
Q1 | $3.29M | Buy |
|
|||||
|
2019
Q4 | $4.05M | Hold |
|
|||||
|
2019
Q3 | $3.49M | Buy |
|
|||||
|
2019
Q2 | $2.35M | Hold |
|
|||||
|
2019
Q1 | $2.83M | Buy |
|
|||||
|
2018
Q4 | $1.99M | Hold |
|
|||||
|
2018
Q3 | $2.61M | Hold |
|
|||||
|
2018
Q2 | $2.69M | Sell |
|
|||||
|
2018
Q1 | $3.97M | Buy |
|
|||||
|
2017
Q4 | $2.04M | Hold |
|
|||||
|
2017
Q3 | $2.31M | Hold |
|
|||||
|
2017
Q2 | $1.39M | Buy |
|
|||||
|
2017
Q1 | $567K | Buy |
|